Antisoma News
Prices
Which 3 Stocks Would Warren Buffett Buy?
23-03-2012
Animalcare Group, a supplier of veterinary medicines, has said that its Project Quatto has received marketing authorisation from the Veterinary Medicines Directorate. The firm can now place the product on the market. The first sales are expected by the end of the current financial year.
25-03-2011
Blue chips closed the week just above 5,900 with decent gains across a range of sectors helped by a smattering of broker recommendations.
25-03-2011
Leading shares are mixed after the strong opening prompted traders to bank some profits at the end of a week which has seen the top share index advance by around 170 points.
25-03-2011
Online gaming software provider Cryptologic, which is also listed on Nasdaq, has appointed Deloitte to help with a strategic review of the company.
02-03-2011
Antisoma has edged lower after further board changes that have led to Michael Bretherton, the finance director of 17.5% shareholder ORA, becoming a director.
16-02-2011
Shares in Asterand have jumped today on the back of two trades.
15-02-2011
AIM-quoted investment company ORA has taken its stake in cancer drug developer Antisoma to 17%.
10-02-2011
Medical products supplier Smith & Nephew reported a strong rise in 2010 profit as well as the departure of its boss.
08-02-2011
The top share index closed with good gains after a late spurt.
08-02-2011
Though miners remain a drag on the index following the Chinese interest rate hike, Footsie struggled back into positive territory over the lunch time session.
08-02-2011
Struggling cancer drug developer Antisoma lost another chunk of its market value on Tuesday after it said it has "initiated the search for a transaction that will deliver maximum value to shareholders from our remaining assets."
04-02-2011
ORA Capital Partners has taken its stake in Antisoma to 14.13% having owned less than 3% at the beginning of the week.
04-02-2011
Antisoma is clawing back some of its losses following stakebuilding by AIM-quoted investment company ORA Capital Partners.
03-02-2011
ORA (Guernsey), a subsidiary of AIM-quoted ORA Capital Partners, has built up an 11.1% stake in fully listed drug developer Antisoma, which has effectively become a shell after poor trial results.
31-01-2011
The FTSE 100 struggled all day to drag itself into the blue after an early slide, but remained slightly in negative territory at the close of trading.
31-01-2011
Footsie is more or less back to square one after a lunchtime trading session which saw US oil giant Exxon announce better than expected fourth quarter figures.
31-01-2011
Antisoma has lost nearly two-thirds of its value after its phase III trial for the AS1413 treatment for secondary acute myeloid leukaemia showed the drug to be ineffective.
31-01-2011
The development of its leukaemia treatment drug AS1413 has been discontinued by cancer drug developer Antimsoma.
14-10-2010
Positive earnings momentum for Vodafone has seen Nomura Securities upgrade its earnings per share forecasts for the telecoms titan by 5-6%.
13-10-2010
Drugs developer Antisoma is higher following its interim management statement which says that it is on track to report phase III trial results for its AS1413 leukaemia treatment in the first half of 2011.
Stock News is provided by Digital Look Corporate Solutions from Sharecast news. Please read the terms and conditions of useage of this data. Republication or redistribution of content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd.
Get a free widget for your website with our latest headlines.
You can now add our live prices and new headlines to your website.The news widget features quotes for Oil prices, spot Gold price and Indices plus a choice of news channel for healines.
| Enter share symbol |
| Search share prices A to Z |
Top Shares pages
- Share price quotes
- Share charts
- Share watch list
- Company Results Calendar
- UK 100 Shares
- Stock market news
- Company news
- Share tips
- A-Z company search
More share features
POPULAR Share Prices
- Lloyds share price
- HSBC share price
- Barclays share price
- Prudential share price
- Diageo share price
- BP share price
- Vodafone share price
- British Airways share price
- Centrica share price
- Tesco share price
- National Grid share price
- RBS share price
- GSK share price
- Marks and Spencer
- Rolls Royce share price
- Banco Santander price
- Rio Tinto share price
- Amec Share price
- Corac share price
- Lookers share price
- Telecom plus share price
- Kier share price
- Punch taverns price
- Blinkx share price
- Tan share price
- Yell share price
- Rsa share price
- Pendragon share price
- Logica share price
- Bat share price
- Sky share price
- Kingfisher share price
- Dragon Oil share price
- Desire Petroleum share price
- RRL share price
- BPC share price
- VOG share price
- SAR share price